Detalhe da pesquisa
1.
Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene.
Proc Natl Acad Sci U S A
; 106(25): 10236-41, 2009 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19497887
2.
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.
Cancer Res
; 66(10): 5104-10, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16707433
3.
Radiation-induced apoptosis varies among individuals and is modified by sex and age.
Int J Radiat Biol
; 90(10): 903-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24882388
4.
A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
Cancer Res
; 72(9): 2206-17, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22389451
5.
Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival.
Cancer Res
; 70(1): 172-80, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19996285
6.
Recent natural selection identifies a genetic variant in a regulatory subunit of protein phosphatase 2A that associates with altered cancer risk and survival.
Clin Cancer Res
; 15(19): 6301-8, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19773383
7.
The genetics of the p53 pathway, apoptosis and cancer therapy.
Nat Rev Drug Discov
; 7(12): 979-87, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19043449
8.
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Cell
; 119(5): 591-602, 2004 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-15550242